NASDAQ:CBUS Cibus 5/9/2024 Earnings Report $2.45 +0.38 (+18.36%) Closing price 05/7/2025 03:59 PM EasternExtended Trading$2.32 -0.13 (-5.47%) As of 05/7/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Earnings HistoryForecast Cibus EPS ResultsActual EPS-$1.12Consensus EPS -$1.01Beat/MissMissed by -$0.11One Year Ago EPS-$5.45Cibus Revenue ResultsActual Revenue$0.55 millionExpected Revenue$0.40 millionBeat/MissBeat by +$150.00 thousandYoY Revenue GrowthN/ACibus Announcement DetailsQuarterDate5/9/2024TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AUpcoming EarningsCibus' next earnings date is estimated for Thursday, May 8, 2025, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany ProfileConference Call Audio Live Call not available Earnings Conference CallCibus 00:00 / 00:00Speed:1x1.25x1.5x2xPowered by Cibus Earnings HeadlinesEcuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional BreedingMay 7 at 7:00 AM | globenewswire.comCibus (CBUS) Expected to Announce Quarterly Earnings on ThursdayMay 7 at 4:05 AM | americanbankingnews.comElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.May 8, 2025 | Brownstone Research (Ad)Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference CallApril 25, 2025 | globenewswire.comUSDA-APHIS Designates Additional Cibus’ Disease Resistance Trait Products as Not RegulatedApril 24, 2025 | finance.yahoo.comCibus, Inc. Announces USDA-APHIS Designation of Disease Resistance Traits for Canola as Not RegulatedApril 24, 2025 | quiverquant.comSee More Cibus Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cibus? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cibus and other key companies, straight to your email. Email Address About CibusCibus (NASDAQ:CBUS), a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.View Cibus ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Disney Stock Jumps on Earnings—Is the Magic Sustainable?Archer Stock Eyes Q1 Earnings After UAE UpdatesFord Motor Stock Rises After Earnings, But Momentum May Not Last Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx BoostPalantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release? Upcoming Earnings Enbridge (5/9/2025)Petróleo Brasileiro S.A. - Petrobras (5/12/2025)Simon Property Group (5/12/2025)JD.com (5/13/2025)NU (5/13/2025)Sony Group (5/13/2025)SEA (5/13/2025)Cisco Systems (5/14/2025)Toyota Motor (5/14/2025)NetEase (5/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
